Form D · Other Health Care

ATOSSA GENETICS INC

Seattle, WA · CIK 0001488039

Offering snapshot reported Apr 11, 2013 · SEC filing

Reported sold
$1M
Offering amount: $30M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 27, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 11, 2013Initial$1,000,000No comparison1SEC filing
Jun 24, 2011Amendment$6,571,000$4,556,000vs May 13, 2011156SEC filing
May 13, 2011Initial$2,015,000No comparison51SEC filing
Sep 28, 2010Amendment$173,000$67,000vs Jun 24, 201048SEC filing
Jun 24, 2010Initial$106,000No comparison48SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$61.1K
Finders' fees
$0
Form D file number
021-194839

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
DAWSON JAMES SECURITIES, INC.130645

Source: Form D, filed Apr 11, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Barnhart Director
Christopher Benjamin Executive
Shu Chih Chen Director, Executive
Alexander Cross Director
Stephen Galli Director
Kyle Guse Executive
Robert Kelly Director, Executive
Steven C. Quay Director, Executive
H. Lawrence Remmel Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
4105 E. Madison Street Suite 320
Seattle, WA, 98112